文献速递心脏核医学

18F-FAPI PET/CT评估PCI术后复发性支架内再狭窄炎症活性:与18F-FDG的前瞻性对比

18F-FAPI PET/CT for Assessing Inflammation-related Activity in Recurrent In-Stent Restenosis After Percutaneous Coronary Intervention: A Prospective Comparison With 18F-FDG.
PubMed 文献 · Clin Nucl Med · 2026-08-10

18F-FAPI对炎症相关ISR的检出率为100%(31/31),显著高于非炎症相关ISR的23.1%(3/13);双示踪剂亚组中18F-FAPI检出20/20(100%),18F-FDG仅检出8/20(40.0%)(P<0.001)。

要点

  • 18F-FAPI PET/CT对炎症相关复发性ISR检出率100%,非炎症相关ISR为23.1%。
  • 双示踪剂亚组中18F-FAPI检出全部20例炎症相关ISR,18F-FDG仅检出8例(40.0%)。
  • 18F-FAPI在炎症相关ISR中视觉评分及SUVmax、SUVmean、TBRblood、TBRliver均显著高于非炎症相关ISR(均P<0.001)。

核心结论

  • 18F-FAPI PET/CT对复发性ISR炎症相关活性的检出率高于18F-FDG PET/CT,病灶-本底对比更优。

研究设计与样本

  • 由多学科裁定将患者分为炎症相关ISR(31例)与非炎症相关ISR(13例),比较视觉与半定量PET参数。

主要发现

  • 18F-FAPI PET/CT在31例炎症相关ISR中全部阳性,非炎症相关ISR仅3/13阳性(100% vs. 23.1%)。
  • 炎症相关ISR的视觉评分、SUVmax、SUVmean、TBRblood、TBRliver均显著高于非炎症相关ISR(均P<0.001)。
  • 双示踪剂亚组(n=32)中18F-FAPI检出全部20例炎症相关ISR(100%),18F-FDG检出8/20(40.0%)(P<0.001)。
  • 与18F-FDG相比,18F-FAPI在炎症相关ISR中视觉评分更高、示踪剂摄取显著更大(均P<0.05)。

临床怎么用

  • 18F-FAPI PET/CT可作为无创评估PCI术后冠状动脉炎症活性的潜在手段,辅助识别炎症相关复发性ISR。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Persistent inflammatory activity may contribute to recurrent in-stent restenosis (ISR) after percutaneous coronary intervention (PCI). This study aimed to evaluate the efficacy of 18F-FAPI PET/CT for detecting inflammation-related activity in recurrent ISR and to compare it with 18F-FDG PET/CT. PATIENTS AND METHODS: Patients with recurrent ISR after PCI and suspected persistent inflammatory mechanisms were prospectively enrolled. All patients underwent 18F-FAPI PET/CT, and 32 also underwent 18F-FDG PET/CT within 1 week. Patients were classified as having inflammation-related ISR or non-inflammation-related ISR by multidisciplinary adjudication. Visual and semiquantitative PET parameters were compared between groups and tracers. RESULTS: Forty-four patients (mean age, 56.8±10.3 y) were included, including 31 with inflammation-related ISR and 13 with non-inflammation-related ISR. 18F-FAPI PET/CT showed positive findings in all 31 patients with inflammation-related ISR, compared with 3 of 13 patients with non-inflammation-related ISR (100% vs. 23.1%). Visual score, SUVmax, SUVmean, TBRblood, and TBRliver were all significantly higher in inflammation-related ISR than in non-inflammation-related ISR (all P<0.001). In the dual-tracer subgroup (n=32), 18F-FAPI PET/CT detected all inflammation-related ISR cases (20/20, 100%), whereas 18F-FDG PET/CT detected 8 of 20 (40.0%) (P<0.001). Compared with 18F-FDG, 18F-FAPI showed higher visual scores and significantly greater tracer uptake in inflammation-related ISR (all P<0.05). CONCLUSIONS: 18F-FAPI PET/CT demonstrated higher detectability of inflammation-related activity in recurrent ISR and provided better lesion-to-background contrast than 18F-FDG PET/CT. These findings support its potential role in the noninvasive assessment of coronary inflammatory activity after PCI.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Xie H, Han X, Nan N, et al. 18F-FAPI PET/CT for Assessing Inflammation-related Activity in Recurrent In-Stent Restenosis After Percutaneous Coronary Intervention: A Prospective Comparison With 18F-FDG. Clin Nucl Med. 2026. PMID: 42853989. doi:10.1097/RLU.0000000000006660

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。